The ureido-substituted sulfamate S4 is a member of an alternative class of CAIX inhibitory molecules that were synthesized with high selectivity for CAIX [25] and exhibited significant anti-proliferative efficacy in vitro in different breast cancer tumor models [26, 27]. Here, CA9 is linked to breast carcinoma.